Growth Metrics

Gilead Sciences (GILD) Total Non-Current Liabilities (2016 - 2025)

Gilead Sciences (GILD) has disclosed Total Non-Current Liabilities for 17 consecutive years, with $35.2 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Non-Current Liabilities fell 8.58% year-over-year to $35.2 billion, compared with a TTM value of $35.2 billion through Dec 2025, down 8.58%, and an annual FY2025 reading of $35.2 billion, down 8.58% over the prior year.
  • Total Non-Current Liabilities was $35.2 billion for Q4 2025 at Gilead Sciences, up from -$866.0 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $48.2 billion in Q1 2021 and bottomed at -$20.9 billion in Q1 2022.
  • Average Total Non-Current Liabilities over 5 years is $26.1 billion, with a median of $38.1 billion recorded in 2023.
  • The sharpest move saw Total Non-Current Liabilities surged 278.16% in 2023, then crashed 160.21% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $45.9 billion in 2021, then fell by 11.17% to $40.8 billion in 2022, then decreased by 6.59% to $38.1 billion in 2023, then grew by 0.94% to $38.5 billion in 2024, then fell by 8.58% to $35.2 billion in 2025.
  • Business Quant data shows Total Non-Current Liabilities for GILD at $35.2 billion in Q4 2025, -$866.0 million in Q3 2025, and -$20.4 billion in Q2 2025.